MDS Pharma Services has been selected as the preferred contract research organization (CRO) of the Multiple Myeloma Research Consortium (MMRC). MDS will manage multiple MMRC preclinical and clinical research efforts, including data management related to the MMRC’s tissue collection program. The MMRC will also recommend MDS to industry partners as additional protocols are brought through the Consortium. “MDS Pharma Services is proud to have been chosen by the MMRC and we are read...